Newsletters

National Zoom Meeting On Wednesday, April 7, at 7:00 pm EST, there will be a national WMFC Zoom meeting where we will discuss a number of topics that will be of interest to all Canadian WMers.  One of the topics that will be discussed is a new clinical trial in the US that one of our members is on.  Please join us.  Here is a link to the meeting: Join Zoom Meeting https://us02web.zoom.us/j/84048441505 Meeting ID: 840 4844 1505 Research Month May 2021 will be Research Month for the WMFC.  We are proud of the research we funded in the past.  We want [...]

Zanubrutinib Approved by Health Canada Today we received notification that Health Canada has accepted Zanubrutinib as a WM treatment.  Here is a link to the announcement from BeiGene:  https://ir.beigene.com/news-releases/news-release-details/health-canada-approves-brukinsar-zanubrutinib-treatment Zanubrutinib is another BTK inhibitor and has tested to have had fewer side effects.  This is good news for WM patients who will have one more option of treatment available to them. Lymphoma Canada Survey The next step for Zanubrutinib to be funded in Canada is for a submission to be made to pCODR and INESSS.  In January the WMFC sent you a link to a survey which many of you [...]

Welcome to 2021 Happy New Year.  Isn’t it great to have 2020 behind us!  Let’s hope the vaccination distribution begins to smooth out and that we are all vaccinated by the late summer. Thank you to all our WMFC supporters.  There are approximately 400 of us, and this year we received almost 300 financial contributions totalling just over $75,000.   This is fantastic support and truly demonstrates the kindness and generosity of WMers across Canada.  Your response has been most impressive during a very, very difficult year.  Thank you from all WMers in Canada for your generosity and support. National Zoom [...]

This site has only one newsletter from 2019. December 2019